Cover Image
市場調查報告書

非阿片類鎮痛藥世界市場:至2022年預測

Non-opioid Pain Treatment: Global Markets to 2022

出版商 BCC Research 商品編碼 606202
出版日期 內容資訊 英文 168 Pages
訂單完成後即時交付
價格
Back to Top
非阿片類鎮痛藥世界市場:至2022年預測 Non-opioid Pain Treatment: Global Markets to 2022
出版日期: 2018年02月20日 內容資訊: 英文 168 Pages
簡介

世界非阿片類鎮痛藥市場預計在預測期間將有18.0%的CAGR (年複合成長率) 變化、從2017年99億美元、成長為2022年的226億美元規模。

本報告針對世界非阿片類鎮痛藥市場調查、提供市場定義與概要、疼痛與疼痛治療目前過程、市場成長的各種影響因素與市場機會分析、疼痛治療代替非阿片類療法各種種類、產品區分、疾病區分、地區/主要國家分類動向與市場規模變化及預測、專利動向、主要企業檔案。

第1章 介紹

第2章 摘要、重點

  • 市場概要
  • 地區市場摘要
  • 促進因素與阻礙

第3章 市場概要、背景

  • 疼痛、疼痛治療歷史
  • 疼痛管理代替方法
  • 疼痛治療代替非阿片類療法
    • 醫療大麻
    • 辣椒素衍生複合物
    • 薄荷醇含複合物
    • 含Omega 3脂肪酸營養補充品
    • 肉毒桿菌毒素
    • 其他
  • 大麻疼痛治療的擴大
    • 醫療大麻的引進:世界分析
    • 法規
    • 有效性
    • 效力、驗證測試
  • 世界邁向緩和醫療
    • 緩和醫療需求分析
    • 對市場影響、成長的指標

第4章 市場分析、預測:產品區分分類

  • 概要
  • 醫療大麻
  • 辣椒素衍生化合物
  • 薄荷醇含複合物
  • 含Omega 3脂肪酸營養補充品
  • 肉毒桿菌毒素

第5章 市場分析、預測:疾病分類

  • 概要
  • 癌症疼痛
  • 神經性疼痛
  • 整形外科/筋骨疼痛
  • 其他

第6章 地區分析

  • 概要
  • 北美
    • 加拿大
    • 美國
  • 歐洲、中東、非洲
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 西班牙
    • 英國
  • 亞太地區
    • 澳洲/紐西蘭
    • 中國
    • 日本
  • 拉丁美洲
    • 阿根廷
    • 巴西
    • 墨西哥

第7章 專利分析

第8章 企業檔案

附錄:用語、情報來源

關於BCC Research

目錄
Product Code: HLC206A

Report Highlights

The global market for non-opioid pain treatment totaled $9.9 billion in 2017 and is estimated to reach $22.6 billion by 2022, growing at a compound annual growth rate (CAGR) of 18.0% for the period of 2017-2022.

Report Includes:

  • 46 data tables and 19 additional tables
  • An overview of the global market for non-opioid pain treatments
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Market breakdown by type, segment, indication, application, and country
  • Identification of segments with high growth potential and their future applications
  • Explanation of major drivers and regional dynamics of the market and current trends within the industry
  • Detailed profiles of major vendors in the market, including Allergan Plc, Aphria Inc., Canopy Growth Corp., Cara Therapeutics and Cronos Group

Report Scope

This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for pain management. The geographical scope of this study is global. This study addresses acute versus chronic pain, treatments and regulatory issues facing healthcare workers. Also provided is detailed information based on product categories, use of products, forecasts and competitive analyses.

The report identifies five general product segments for non-opioid treatment of pain:

  • Medical cannabis treatments.
  • Capsaicin-derived treatments.
  • Menthol-containing treatments.
  • Omega 3 fatty acid-containing treatments.
  • Botulinum toxins.

Within the segment several sub-segments are discussed as they pertain to each product segment; diseases or disorders are the basis for these sub-segments, including:

  • Arthritis.
  • Cancer-brain, breast, colorectal, leukemia/lymphoma, melanoma, prostate, others.
  • Dental.
  • Epilepsy.
  • Fibromyalgia.
  • Migraine.
  • Multiple sclerosis.
  • Surgical.

A regional analysis of these product segments is also provided, including the specific countries listed below and including countries not listed as a “rest of the world” market.

  • Argentina.
  • Australia/New Zealand.
  • Brazil.
  • Canada.
  • China.
  • France.
  • Germany.
  • Italy.
  • Japan.
  • Mexico.
  • Russia.
  • Spain.
  • United Kingdom.
  • United States.

Each market segment provides detailed information based on product categories, product use, current market value and forecasts.

Not covered in the report are drugs or devices that are considered “conventional” in professional treatment guidelines that are due to either controversial issues such as those with medical cannabis or those that are not commonly prescribed or recommended due to a lack of clinical data, education or other factors.

Analyst Credentials

MELISSA ELDER is a healthcare market analyst specializing in treatments, medical equipment and devices. As a research analyst for more than 20 years, she also worked in medical training and advanced medical technologies. She holds a B.S. degree in business management and is pursuing an MBA in health care management from California Coast University.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

  • Market Overview
  • Regional Market Summary
  • Drivers and Restraints

Chapter 3: Market Overview and Background

  • History of Pain and Pain Treatment
    • Types of Pain
    • Physiological Pain Classifications
    • How Pain is Diagnosed
    • How Pain is Treated
    • Opioid vs. Non-opioid Pain Control
  • Alternative Methods of Pain Management
  • Alternative Non-opioid Therapies for Treating Pain
    • Medical Cannabis
    • Capsaicin-derived Compound
    • Menthol-containing Compound
    • Omega 3 Fatty Acid-containing Supplements
    • Botulinum Toxins (OnabotulinumtoxinA/RimabotulinumtoxinB)
    • Others
  • Growing Trend in Cannabis Treatment for Pain
    • Adoption of Medical Cannabis: A Global Analysis
    • Laws and Legalization Trends
    • Claims in Effectiveness
    • Potency and Validation Testing Trends
  • Access to Palliative Care Around the World
    • Assessing the Need for Palliative Care
    • Market Influences and Indicators of Growth

Chapter 4: Market Breakdown by Product Segment

  • Overview
  • Medical Cannabis
  • Capsaicin-derived Therapies
  • Menthol-containing Therapies
  • Omega-3 Fatty Acid-containing Therapies
  • Botulinum Toxin Treatments

Chapter 5: Market Breakdown by Therapeutic Application

  • Overview
  • Alternative Non-opioid Cancer Pain Treatment
  • Alternative Non-opioid Neuropathic Pain Treatment
  • Alternative Non-opioid Orthopedic/Musculoskeletal Pain Treatments
  • Other Alternative Non-opioid Pain Treatments

Chapter 6: Market Breakdown by Region

  • Overview
    • Regional Groupings
  • North America
    • Canada
    • United States
  • EMEA
    • France
    • Germany
    • Italy
    • Russia
    • Spain
    • United Kingdom
  • Asia-Pacific
    • Australia/New Zealand
    • China
    • Japan
  • Latin America
    • Argentina
    • Brazil
    • Mexico

Chapter 7: Patent Analysis

  • Patent Analysis Overview
  • Non-opioid Pain Relief Categories
  • Medical Cannabis
    • Technologies
    • Cannabis Patent Review by Year
    • Patent Review by Company
    • Patent Review by Major Country
    • Patent Review by Assignee

Chapter 8: Company Profiles

Appendix: Terminology and Sources of Information

About BCC Research

  • About BCC Research
  • BCC Membership
  • BCC Custom Research

List of Tables

Table A: Major Countries, by Region

  • Summary Table: Global Market for Non-opioid Pain Treatments, by Product Segment, Through 2022 ($ Millions)
    • Table 1: Physiological Effects of Pain
    • Table 2: United States Opioid Addiction and Abuse Statistics
    • Table 3: Global Opioid Addiction and Abuse Statistics
    • Table 4: List of Brand Name Extended-release and Long-acting Opioid Products Required to be Included in Opioid REMS (Updated May 2017)
    • Table 5: List of Generic Extended-release and Long-acting Opioid Products Required to be Included in Opioid REMS (Updated May 2017)
    • Table 6: List of Transmucosal Immediate-release Fentanyl Products Required to be Included in the TIRF REMS Access Program
    • Table 7: Adoption of Medical Cannabis, by Select Country (Age 15 and Over), 2017 (%/Thousands)
    • Table 8: Medical Cannabis Programs, by U.S. State
    • Table 9: Top Five U.S. States with Medical Cannabis Applications/Registrations (No./%)
    • Table 10: Effectiveness of Fibromyalgia Treatments: Cannabis vs. Pharmaceutical Therapies (%)
    • Table 11: Hospice Statistics, Patient Characteristics, 2009-2014 (Total in Thousands; % of Total)
    • Table 12: Hospice Statistics, Patients, by Primary Diagnosis, 2009-2014 (Total in Thousands; % of Total)
    • Table 13: Global Population, by Select Country, 2017 and 2022 (Millions of Population)
    • Table 14: Global Population, Age 65+, by Select Country, 2017 and 2022 (Thousands of Population)
    • Table 15: Global Life Expectancy at Birth, by Select Country, 1980, 2010 and 2020 Projections (Both Genders Combined) (Years)
    • Table 16: Global Non-opioid Pain Treatment Market, by Product Segment, Through 2022 ($ Millions)
    • Table 17: Global Market Shares of Non-opioid Pain Treatments, by Product Segment, 2017 (%)
    • Table 18: Selected Cannabis Clinical Trials for Pain Treatment (Current Through Nov. 30, 2017)
    • Table 19: Global Medical Cannabis Pain Treatment Market by Indication, Through 2022 ($ Millions)
    • Table 20: Global Market Shares of Medical Cannabis Pain Treatments, by Indication, 2017 (%)
    • Table 21: Selected Capsaicin-derived Clinical Trials for Pain Treatment (Current Through Nov. 30, 2017)
    • Table 22: Global Capsaicin-derived Pain Treatment Market, by Indication, Through 2022 ($ Millions)
    • Table 23: Global Market Shares of Capsaicin-derived Pain Treatments, by Indication, 2017 (%)
    • Table 24: Selected Menthol-containing Clinical Trials for Pain Treatment (Current Through Nov. 30, 2017)
    • Table 25: Global Menthol-containing Pain Treatment Market, by Indication, Through 2022 ($ Millions)
    • Table 26: Global Market Shares of Menthol-containing Pain Treatments, by Indication, 2017 (%)
    • Table 27: Selected Omega-3 Fatty Acid-containing Clinical Trials for Pain Treatment (Current Through Nov. 30, 2017)
    • Table 28: Global Omega-3 Fatty Acid-containing Pain Treatment Market, by Indication, Through 2022 ($ Millions)
    • Table 29: Global Market Shares of Omega-3 Fatty Acid-containing Pain Treatments, by Indication, 2017 (%)
    • Table 30: U.S. Market for Allergan's Botox, by Treatment Area, 2016 ($ Millions/%)
    • Table 31: U.S. Market for Allergan's Botox, by Treatment Area, 2017 ($ Millions/%)
    • Table 32: Selected Botulinum Toxin Clinical Trials for Pain Treatment (Current Through Nov. 30, 2017)
    • Table 33: Global Botulinum Toxin Pain Treatment Market, by Indication, Through 2022 ($ Millions)
    • Table 34: Global Market for Botulinum Toxin Pain Treatments, by Indication, 2017 (%)
    • Table 35: Global Non-opioid Pain Treatment Market, by Therapeutic Application, Through 2022 ($ Millions)
    • Table 36: Global Market Shares of Non-opioid Pain Treatments, by Therapeutic Application, 2017 (%)
    • Table 37: Global Non-opioid Cancer Pain Treatment Market, by Product Segment, Through 2022 ($ Millions)
    • Table 38: Global Market Shares of Non-opioid Cancer Pain Treatments, by Product Segment, 2017 (%)
    • Table 39: Global Market Shares of Non-opioid Cancer Pain Treatments, by Cancer Type, 2017 (%)
    • Table 40: Global Non-opioid Neuropathic Pain Treatment Market, by Product Segment, Through 2022 ($ Millions)
    • Table 41: Global Market Shares of Non-opioid Neuropathic Pain Treatments, by Product Segment, 2017 (%)
    • Table 42: Global Market Shares of Non-opioid Neuropathic Pain Treatments, by Disease/Disorder Type, 2017 (%)
    • Table 43: Global Non-opioid Orthopedic/Musculoskeletal Pain Treatment Market, by Product Segment, Through 2022 ($ Millions)
    • Table 44: Global Market Shares of Non-opioid Orthopedic/Musculoskeletal Pain Treatments, by Product Segment, 2017 (%)
    • Table 45: Global Market Shares of Non-opioid Orthopedic/Musculoskeletal Pain Treatments, by Disease/Disorder Type, 2017 (%)
    • Table 46: Global Market for Other Non-opioid Pain Treatments, by Product Segment, Through 2022 ($ Millions)
    • Table 47: Global Market Shares of Other Non-opioid Pain Treatments, by Product Segment, 2017 (%)
    • Table 48: Global Market Shares of Other Non-opioid Pain Treatments, by Disease/Disorder Type, 2017 (%)
    • Table 49: Global Non-opioid Pain Treatment Market, by Region, Through 2022 ($ Millions)
    • Table 50: Global Market Shares of Non-opioid Pain Treatments, by Region, 2017 (%)
    • Table 51: Regional Grouping: Countries, by Region
    • Table 52: North American Non-opioid Pain Treatment Market, by Country, Through 2022 ($ Millions)
    • Table 53: EMEA Non-opioid Pain Treatment Market, by Country, Through 2022 ($ Millions)
    • Table 54: Asia-Pacific Non-opioid Pain Treatment Market, by Country, Through 2022 ($ Millions)
    • Table 55: Latin American Non-opioid Pain Treatment Market, by Country, Through 2022 ($ Millions)
    • Table 56: U.S. Patents Related to Medical Cannabis, by Type, Through 2017 (Number/% Share of Total)
    • Table 57: U.S. Patents on Medical Cannabis Technologies, by Type, Through 2017 (Number/% Share of Total)
    • Table 58: Notable U.S. Patents Related to Medical Cannabis, by Company, Through 2017 (Number)
    • Table 59: List of U.S. Patents Related to Medical Cannabis, July 2017-Nov. 2017
    • Table 60: Notable Developments in Non-opioid Pain Relief, Through 2017
    • Table 61: Glossary of Terms Used in Non-opioid Pain Treatment
    • Table 62: Global Pain Societies and Organizations
    • Table 63: Report Sources

List of Figures

Summary Figure: Global Market for Non-opioid Pain Treatments, by Product Segment, 2016-2022 ($ Millions) Figure 1: Non-opioid Pain Management Market Drivers and Restraints Figure 2: Pain Management Techniques Figure 3: Total Hospice Patients Served, by Year, 2009-2014 (No. of Patients) Figure 4: Distribution of Causes of Mortality and Potential Need for Palliative Care, 2017 (Millions) Figure 5: Global Population, by Country, 2017 and 2022 (Millions) Figure 6: Global Population Age 65+, by Country, 2017 and 2022 (Millions) Figure 7: Global Life Expectancy at Birth, by Select Country, 1980, 2010 and 2020 Projections (Years) Figure 8: Global Non-opioid Pain Treatment Market, by Product Segment, 2016-2022 ($ Millions) Figure 9: Global Market Shares of Non-opioid Pain Treatments, by Product Segment, 2017 (%) Figure 10: Global Market Shares of Medical Cannabis: Pain vs. All Other Uses, 2017 (%) Figure 11: Global Medical Cannabis Pain Treatment Market, by Indication, 2016-2022 ($ Millions) Figure 12: Global Market Shares of Medical Cannabis Pain Treatments, by Indication, 2017 (%) Figure 13: Global Capsaicin-derived Pain Treatment Market, by Indication, 2016-2022 ($ Millions) Figure 14: Global Market Shares of Capsaicin-derived Pain Treatments, by Indication, 2017 (%) Figure 15: Global Menthol-containing Pain Treatment Market, by Indication, 2016-2022 ($ Millions) Figure 16: Global Market Shares of Menthol-containing Pain Treatments, by Indication, 2017 (%) Figure 17: Global Omega-3 Fatty Acid-containing Pain Treatment Market, by Indication, 2016-2022 ($ Millions) Figure 18: Global Market Shares of Omega-3 Fatty Acid-containing Pain Treatments, by Indication, 2017 (%) Figure 19: Global Botulinum Toxin Pain Treatment Market, by Indication, 2016-2022 ($ Millions) Figure 20: Global Market Shares of Botulinum Toxin Pain Treatments, by Indication, 2017 (%) Figure 21: Global Non-opioid Pain Treatment Market, by Therapeutic Application, 2016-2022 ($ Millions) Figure 22: Global Market Shares of Non-opioid Pain Treatments, by Therapeutic Application, 2017 (%) Figure 23: Global Non-opioid Cancer Pain Treatment Market, by Product Segment, 2016-2022 ($ Millions) Figure 24: Global Market Shares of Non-opioid Cancer Pain Treatments, by Product Segment, 2017 (%) Figure 25: Global Market Shares of Non-opioid Cancer Pain Treatments, by Cancer Type, 2017 (%) Figure 26: Global Non-opioid Neuropathic Pain Treatment Market, by Product Segment, 2016-2022 ($ Millions) Figure 27: Global Market Shares of Sales of Non-opioid Neuropathic Pain Treatments, by Product Segment, 2017 (%) Figure 28: Global Market Shares of Non-opioid Neuropathic Pain Treatments, by Disease/Disorder Type, 2017 (%) Figure 29: Global Non-opioid Orthopedic/Musculoskeletal Pain Treatment Market, by Product Segment, 2016-2022 ($ Millions) Figure 30: Global Market Shares of Non-opioid Orthopedic/Musculoskeletal Pain Treatments, by Product Segment, 2017 (%) Figure 31: Global Market Shares of Non-opioid Orthopedic/Musculoskeletal Pain Treatments, by Disease/Disorder Type, 2017 (%) Figure 32: Global Market for Other Non-opioid Pain Treatments, by Product Segment, 2016-2022 ($ Millions) Figure 33: Global Market Shares of Other Non-opioid Pain Treatments, by Product Segment, 2017 (%) Figure 34: Global Market Shares of Other Non-opioid Pain Treatments, by Disease/Disorder Type, 2017 (%) Figure 35: Global Non-opioid Pain Treatment Market, by Region, 2016-2022 ($ Millions) Figure 36: Global Market Shares of Non-opioid Pain Treatments, by Region, 2017 (%) Figure 37: North American Non-opioid Pain Treatment Market, by Country, 2016-2022 ($ Millions) Figure 38: North American Market Shares of Alternative Non-opioid Pain Treatments, by Country, 2017 (%) Figure 39: Canadian Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2017 (%) Figure 40: Canadian Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2017 (%) Figure 41: Canadian Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2017 (%) Figure 42: Canadian Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2017 (%) Figure 43: EMEA Non-opioid Pain Treatment Market, by Country, 2016-2022 ($ Millions) Figure 44: EMEA Market Shares of Alternative Non-opioid Pain Treatments, by Country, 2017 (%) Figure 45: French Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2017 (%) Figure 46: French Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2017 (%) Figure 47: German Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2017 (%) Figure 48: German Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2017 (%) Figure 49: Italian Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2017 (%) Figure 50: Italian Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2017 (%) Figure 51: Russian Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2017 (%) Figure 52: Russian Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2017 (%) Figure 53: Spanish Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2017 (%) Figure 54: Spanish Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2017 (%) Figure 55: U.K. Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2017 (%) Figure 56: U.K. Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2017 (%) Figure 57: Asia-Pacific Non-opioid Pain Treatment Market, by Country, 2016-2022 ($ Millions) Figure 58: Asia-Pacific Market Shares of Alternative Non-opioid Pain Treatments, by Country, 2017 (%) Figure 59: Australia/New Zealand's Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2017 (%) Figure 60: Australia/New Zealand's Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2017 (%) Figure 61: Chinese Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2017 (%) Figure 62: Chinese Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2017 (%) Figure 63: Japanese Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2017 (%) Figure 64: Japanese Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2017 (%) Figure 65: Latin American Non-opioid Pain Treatment Market, by Country, 2016-2022 ($ Millions) Figure 66: Latin American Market Shares of Alternative Non-opioid Pain Treatments, by Country, 2017 (%) Figure 67: Argentinean Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2017 (%) Figure 68: Argentinean Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2017 (%) Figure 69: Brazilian Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2017 (%) Figure 70: Brazilian Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2017 (%) Figure 71: Mexican Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2017 (%) Figure 72: Mexican Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2017 (%) Figure 73: Total U.S. Patents on Non-opioid Pain Treatments, by Type, Through 2017 (Number/% Share of Total) Figure 74: Shares of U.S. Patents Related to Medical Cannabis, by Type, Through 2017 (%) Figure 75: Shares of U.S. Patents on Medical Cannabis Technologies, by Type, Through 2017 (%)

Back to Top